SP would need to increase 300% from here to even get a look in for December inclusion, but that’s excluding volume and weighting criteria.
BRN is more likely to be removed from the ASX300 index during next rebalance, than be included in the ASX200 IMO.
- Forums
- ASX - By Stock
- S&P/ASX 300 March rebalance
SP would need to increase 300% from here to even get a look in...
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.0¢ |
Change
0.045(17.0%) |
Mkt cap ! $608.3M |
Open | High | Low | Value | Volume |
26.5¢ | 32.3¢ | 26.5¢ | $13.67M | 45.36M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 20364 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 653900 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 20364 | 0.310 |
8 | 158991 | 0.305 |
36 | 867594 | 0.300 |
11 | 1023313 | 0.295 |
16 | 553133 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 653900 | 10 |
0.320 | 588638 | 22 |
0.325 | 392901 | 18 |
0.330 | 182875 | 16 |
0.335 | 130980 | 9 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online